Sildenafil
Product Images NDC 53002-1719
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 53002-1719). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
Image 3
This text is a list of drugs and their potential interaction with sildenafil (brand name: Viagra). It includes information on whether a dose adjustment is recommended, as well as the fold change and 90% confidence interval for certain drugs. The text also notes that the combination of sildenafil and bosentan may not have any benefit on exercise capacity.*
Image 4
This is a list of drugs and their interaction with Acenocoumarol, with recommended dosage adjustments. The interaction is measured based on Fold Change and 90% CI, where recommendations are given for Interaction Ratio AUC, Cmax, BT, and AuC, among others. There is also a chart showing the change relative to the interacting drug alone. There are notes indicating when a drug may not be recommended or when there may not be a benefit.*
Image 5
Image 6
Image 7
Image 8
Label Image (Lbl530021719)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.